Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bondarenko, I.
3672  Ergebnisse:
Personensuche X
?
1

Virtual endomorphisms of the group $pg$:

Bondarenko, I. ; Zashkolny, D.
Researches in Mathematics.  32 (2024)  1 - p. 3 , 2024
Link: https://doi.org/10.15421..
 
?
2

114M0 First-line cemiplimab for locally advanced non-small ..:

Kalinka, E. ; Bondarenko, I. ; Gogishvili, M....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S106 , 2023
Link: https://doi.org/10.1016/..
 
?
3

OA01.05 Three-year Outcomes per PD-L1 Status and Continued ..:

Garassino, M.C. ; Kilickap, S. ; Özgüroğlu, M....
Journal of Thoracic Oncology.  18 (2023)  3 - p. e2-e3 , 2023
Link: https://doi.org/10.1016/..
 
?
4

A phase Ib/II dose expansion study of subcutaneous sasanlim..:

Cho, B.C. ; Penkov, K. ; Bondarenko, I....
ESMO Open.  8 (2023)  4 - p. 101589 , 2023
Link: https://doi.org/10.1016/..
 
?
5

10MO EMPOWER-Lung 1: Cemiplimab (CEMI) monotherapy as first..:

Kilickap, S. ; Özgüroğlu, M. ; Sezer, A....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S42-S43 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P2.06-10 Disease Progression on PROs in Patients With aNSCL..:

Gümüs, M. ; Kilickap, S. ; Sezer, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S321 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Patient-reported outcomes (PROs) of cemiplimab (CEMI) versu..:

Gogishvili, M. ; Kilickap, S. ; Sezer, A....
Journal of Geriatric Oncology.  13 (2022)  8 - p. S3 , 2022
Link: https://doi.org/10.1016/..
 
?
8

PL03.09 IMpower010:Overall Survival Interim Analysis of a P..:

Wakelee, H. ; Altorki, N. ; Felip, E....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S2 , 2022
Link: https://doi.org/10.1016/..
 
?
9

P1.15-11 Durvalumab + Olaparib vs Durvalumab Alone as Maint..:

Ahn, M-j. ; Spigel, D. ; Bondarenko, I....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S124-S125 , 2022
Link: https://doi.org/10.1016/..
 
?
10

P1.15-12 Patient-reported Outcomes of Cemiplimab versus Che..:

Kilickap, S. ; Sezer, A. ; Gümüş, M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S125-S126 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Durvalumab, with or without tremelimumab, plus platinum-eto..:

Paz-Ares, L. ; Chen, Y. ; Reinmuth, N....
ESMO Open.  7 (2022)  2 - p. 100408 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Final results from the PERUSE study of first-line pertuzuma..:

Miles, D. ; Ciruelos, E. ; Schneeweiss, A....
Annals of Oncology.  32 (2021)  10 - p. 1245-1255 , 2021
Link: https://doi.org/10.1016/..
 
?
13

On Cryptographic Properties of the NB-Fi Protocol:

Alekseev, E. K. ; Akhmetzyanova, L. R. ; Nikolaev, V. D...
Automatic Control and Computer Sciences.  55 (2021)  8 - p. 1180-1187 , 2021
Link: https://doi.org/10.3103/..
 
?
14

Immunotropic effect of medicinal plants with different micr..:

Ivanova, E. V. ; Voronkova, I. P. ; Bondarenko, A. I..
Russian Journal of Immunology.  24 (2021)  2 - p. 331-336 , 2021
Link: https://doi.org/10.46235..
 
?
15

CHRONOS‐3: RANDOMIZED PHASE III STUDY OF COPANLISIB PLUS RI..:

Zinzani, P. L. ; Capra, M. ; Özcan, M....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15